Literature DB >> 4362100

Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma.

S L Lightman, S R Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4362100      PMCID： PMC1633613          DOI： 10.1136/bmj.1.5904.367

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  8 in total

1.  The pathologic effects of large amounts of glucagon.

Authors:  J M SALTER; I W DAVIDSON; C H BEST
Journal:  Diabetes       Date:  1957 May-Jun       Impact factor: 9.461

2.  Extractable glucagon of the human pancreas.

Authors:  A J KENNY
Journal:  J Clin Endocrinol Metab       Date:  1955-09       Impact factor: 5.958

3.  A cutaneous syndrome associated with islet-cell carcinoma of the pancreas.

Authors:  R E Church; W A Crane
Journal:  Br J Dermatol       Date:  1967-05       Impact factor: 9.302

4.  Effect of glucagon on glucose turnover and plasma free fatty acids in depancreatized dogs maintained on matched insulin infusions.

Authors:  A Cherrington; M Vranic; P Fono; N Kovacevic
Journal:  Can J Physiol Pharmacol       Date:  1972-10       Impact factor: 2.273

5.  Effects of long-term infusion of glucagon on carbohydrate metabolism, insulin and growth hormone secretion in patients with congestive heart failure.

Authors:  H M Frey; D Falch; K Forfang; N Norman; D Fremstad
Journal:  Diabetes       Date:  1972-09       Impact factor: 9.461

6.  Autoerythrocyte sensitization (painful bruising) syndrome.

Authors:  J D Boxley; D S Wilkinson
Journal:  Proc R Soc Med       Date:  1971-12

7.  Pancreatic A-cell tumor associated with severe diabetes mellitus.

Authors:  T Yoshinaga; G Okuno; Y Shinji; T Tsujii; M Nishikawa
Journal:  Diabetes       Date:  1966-10       Impact factor: 9.461

8.  Studies of pancreatic alpha cell function in normal and diabetic subjects.

Authors:  R H Unger; E Aguilar-Parada; W A Müller; A M Eisentraut
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808
  8 in total
  9 in total

1.  Glucagonoma syndrome in a 19-year-old woman.

Authors:  M C Riddle; T A Golper; W S Fletcher; J W Ensinck; P H Smith
Journal:  West J Med       Date:  1978-07

2.  Glucagonoma syndrome in a young man.

Authors:  N G Soler; G D Oates; J M Malins
Journal:  Proc R Soc Med       Date:  1976-06

3.  Inhibition of glucagon secretion by diphenylhydantoin in a patient with glucagonoma.

Authors:  T Machina; R Marcus; S R Levin
Journal:  West J Med       Date:  1980-04

4.  Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man.

Authors:  D S Schade; P R Eaton
Journal:  Acta Diabetol Lat       Date:  1977 Jan-Apr

5.  Glucagonoma syndrome demonstrating giant duodenal villi.

Authors:  F M Stevens; R W Flanagan; D O'Gorman; K D Buchanan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 6.  Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature.

Authors:  E Ruttman; G Klöppel; G Bommer; M Kiehn; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

7.  Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".

Authors:  L Recant; P V Perrino; S J Bhathena; D N Danforth; R L Lavine
Journal:  Diabetologia       Date:  1976-08       Impact factor: 10.122

8.  Functional studies in patients with the glucagonoma syndrome.

Authors:  J J Holst; S Helland; S Ingemannson; N B Pedersen; H von Schenck
Journal:  Diabetologia       Date:  1979-09       Impact factor: 10.122

9.  Pancreatic apudomas.

Authors:  S R Bloom; J M Polak; R B Welbourn
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.